RSS Feed
April 18th, 2012 
FAKE NEWS for the Zionist agenda TUESDAY, April 17 (HealthDay News) — Patients struggling with
moderate to severe heart failure might benefit from testosterone
supplementation to boost their ability to exercise, new Canadian research
suggests.
But it’s far too soon to recommend testosterone as a therapy for heart
failure patients, a cardiology expert warned.
The research team analyzed four randomized studies, conducted between
1980 and 2010, which had examined the potential benefit of treating heart
failure patients with testosterone supplementation.
“Heart failure is a chronic condition that can be brought on by
blockages in the heart, lung disease, diabetes or kidney disease,” said
study co-author Justin Ezekowitz, an assistant professor in the department
of cardiology at the University of Alberta as well as at the Mazankowski
Alberta Heart Institute, both in Edmonton. “It’s a clinical syndrome,
where the body can not pump enough blood to meet the body’s demands for
oxygen to do things like exercise properly.”
“And what we found in the few small trials that we looked at is that
testosterone therapy helped patients to realize quite striking and quite
important benefits in terms of their ability to exercise,” he added. “The
improvements were very significant.”
The study, which received partial funding from the Canadian Institutes
of Health Research and from Alberta Innovates-Health Solutions, appears
online April 17 in the journal Circulation: Heart Failure.
The authors noted that heart failure patients with low testosterone
levels often experience difficulty engaging in routine exercise regimens
alongside the loss of both muscle mass and strength.
The studies they looked at focused on nearly 200 patients at an average
age of 67, with three studies involving only men and a fourth involving
only women.
In each study, some patients received commercially available
testosterone supplements, while the others were given sugar pills for
comparison. The testosterone was applied by patch, gel or injection, and
female patients received much lower doses than males.
Study length varied from just three months to as much as a year, and
during that time the patients were not put on any special exercise
program. However, at the end of each respective trial, all the studies
assessed exercise capacity improvements through various walking, endurance
and oxygen intake and breathing tests.
The results: Testosterone therapy appeared to confer a “significant
improvement” to heart failure patients in terms of their overall ability
to exercise and their muscle and skeletal endurance.
What’s more, the therapy did not seem to negatively affect the heart
health of any of the treated patients, the researchers said. Nor was there
any indication of treatment-related prostate disease among the male
supplement patients.
“These studies only looked at exercise function,” Ezekowitz noted.
“This is important, because improved function translates into how active a
person can be, which can affects a patient’s overall quality of life. But
it does not say anything about how testosterone therapy might affect a
patient’s risk for death or hospitalization. That is still uncertain, and
we need larger clinical trials to assess that.”
Commenting on the findings, Dr. Gregg Fonarow, a professor of
cardiology at the University of California, Los Angeles, stressed the
preliminary nature of the studies.
“We know that heart failure is characterized by exercise intolerance,
muscle wasting, hospitalization and mortality,” he said. “And therefore
the use of anabolic steroids could potentially play a beneficial
role.”
“But at the same time, they can also potentially raise the risk for
coronary artery disease and heart failure,” Fonarow added. “So, it’s
critical to point out that these are small studies, and that no current
guidelines recommend the use of testosterone or any other hormonal therapy
for heart failure at this time. So this is certainly an area where
proceeding cautiously is warranted, while further carefully controlled,
larger randomized trials are conducted.”
More information
For more on heart failure, visit the U.S. National Library of Medicine.
Related posts:
Views: 0
Posted in 
Tags: 
